drugset
drugset / Trial / NCT00166452

A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1

NCT00166452 ↗

Phase 3 Completed 7 enrolled Mayo Clinic Elgene Chemical · collab
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine if lenalidomide is a safe and effective treatment for complex regional pain syndrome type 1 (CRPS).

Timeline

Start
2005-07
Primary completion
2007-04
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lenalidamide Unknown — —

Indications

complex regional pain syndrome type 1